Multiple studies have revealed the upregulation of EGFR-AS1 in the tumor tissues and cells of head and neck cancer, including oral squamous cell carcinoma and esophageal squamous cell carcinoma (ESCC) (49–51). This evidence concerns the gene EGFR and oral cavity squamous cell carcinoma.